Higher visit-to-visit intra-dialytic blood pressure is associated with the progression of aortic valve stenosis in chronic hemodialysis patients

• Published in: Heart and vessels Vol. 31; no. 9; pp. 1491 - 1496
• Main Authors: Norioka, Naoki, Iwata, Shinichi, Yanagi, Shiro, Ishii, Hideshi, Sugioka, Kenichi, Kamimori, Kimio, Ota, Takahiro, Di Tullio, Marco R., Homma, Shunichi, Yoshiyama, Minoru
• Format: Journal Article
• Language: English
• Published: Tokyo Springer Japan 01.09.2016; Springer Nature B.V
• Subjects: Aged; Aortic Valve Stenosis - diagnostic imaging; Aortic Valve Stenosis - etiology; Aortic Valve Stenosis - physiopathology; Biomedical Engineering and Bioengineering; Blood Pressure; Blood Pressure Determination; Cardiac Surgery; Cardiology; Disease Progression; Echocardiography, Doppler; Female; Hemodialysis; Humans; Hypertension - complications; Hypertension - diagnosis; Hypertension - physiopathology; Male; Medical prognosis; Medicine; Medicine & Public Health; Middle Aged; Original Article; Renal Dialysis - adverse effects; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - diagnosis; Renal Insufficiency, Chronic - physiopathology; Renal Insufficiency, Chronic - therapy; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vascular Surgery; Blood pressure; Blood pressure variability; Chronic hemodialysis; Aortic valve stenosis
• ISSN: 0910-8327; 1615-2573
• DOI: 10.1007/s00380-015-0756-z

Aortic valve stenosis (AS) is a frequent complication contributing to poor prognosis in chronic hemodialysis (CHD) patients. High blood pressure (BP) is known to be associated with AS progression in the general population. In CHD patients, however, BP varies during and between hemodialysis sessions with ultrafiltration volume or inter-dialytic weight gain; therefore it is difficult to characterize the BP status with a conventional single measurement. Our purpose was to clarify the BP variables affecting AS progression in CHD patients. We retrospectively enrolled 32 consecutive CHD patients with AS [aortic valve area (AVA), 1.3 ± 0.3 cm 2 ; mean age 69 ± 8 years] who had serial transthoracic echocardiographic studies at least 6 months apart (mean 23 ± 9 months). AS progression was evaluated using absolute reduction in AVA per year. Pre-dialytic and intra-dialytic (every hour during sessions) BPs throughout the 3 consecutive visits were used to determine each patient’s BP status. We calculated the mean values of pre-dialytic and intra-dialytic BPs and their variability. In univariate analysis, mean visit-to-visit pre-dialytic and intra-dialytic BP were associated with AS progression, whereas all variables of BP variability were not. Multiple regression analysis indicated that only mean visit-to-visit intra-dialytic systolic and diastolic BP remained independently associated with AS progression after adjustment for age, sex, hypertension, hypercholesterolemia, diabetes mellitus, and serum parathyroid hormone ( p  < 0.05). Although BP regulation in CHD patients is complex and multifactorial, mean visit-to-visit intra-dialytic BP was independently associated with AS progression. Prospective studies are necessary before considering intra-dialytic BP as a potential target for therapy.